[HTML][HTML] Standards for quantification of EMG and neurography
E Stålberg, H van Dijk, B Falck, J Kimura… - Clinical …, 2019 - Elsevier
This document is an update and extension of ICCN Standards published in 1999. It is the
consensus of experts on the current status of EMG and Neurography methods. A panel of …
consensus of experts on the current status of EMG and Neurography methods. A panel of …
Biomarkers in motor neuron disease: a state of the art review
NS Verber, SR Shepheard, M Sassani… - Frontiers in …, 2019 - frontiersin.org
Motor neuron disease can be viewed as an umbrella term describing a heterogeneous
group of conditions, all of which are relentlessly progressive and ultimately fatal. The …
group of conditions, all of which are relentlessly progressive and ultimately fatal. The …
Biomarkers in amyotrophic lateral sclerosis: current status and future prospects
Disease heterogeneity in amyotrophic lateral sclerosis poses a substantial challenge in drug
development. Categorization based on clinical features alone can help us predict the …
development. Categorization based on clinical features alone can help us predict the …
Estimating motor unit numbers from a CMAP scan: Repeatability study on three muscles at 15 centres
Objective To assess the repeatability and suitability for multicentre studies of MScanFit motor
unit number estimation (MUNE), which involves modelling compound muscle action …
unit number estimation (MUNE), which involves modelling compound muscle action …
Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study
S Vucic, RD Henderson, S Mathers… - Annals of Clinical …, 2021 - Wiley Online Library
Objective Neuroinflammation is an important pathogenic mechanism in amyotrophic lateral
sclerosis (ALS), with regulatory T cells (Tregs) mediating a slower rate of disease …
sclerosis (ALS), with regulatory T cells (Tregs) mediating a slower rate of disease …
Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis
DJL Stikvoort García, B Sleutjes… - European Journal of …, 2023 - Wiley Online Library
Background and purpose The lack of reliable early biomarkers still causes substantial
diagnostic delays in amyotrophic lateral sclerosis (ALS). The aim was to assess the …
diagnostic delays in amyotrophic lateral sclerosis (ALS). The aim was to assess the …
[HTML][HTML] The evolving role of surface electromyography in amyotrophic lateral sclerosis: A systematic review
J Bashford, K Mills, C Shaw - Clinical Neurophysiology, 2020 - Elsevier
Objective Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease
that leads to inexorable motor decline and a median survival of three years from symptom …
that leads to inexorable motor decline and a median survival of three years from symptom …
Assessing inter-rater reproducibility in MScanFit MUNE in a 6-subject, 12-rater “Round Robin” setup
DM Sørensen, H Bostock, M Ballegaard… - Neurophysiologie …, 2022 - Elsevier
Objective To assess the inter-rater reliability of MScanFit MUNE using a “Round Robin”
research design. Methods Twelve raters from different centres examined six healthy study …
research design. Methods Twelve raters from different centres examined six healthy study …
Motor unit number index and compound muscle action potential amplitude
Objectives MUNIX (motor unit number index), derived from the compound muscle action
potential (CMAP) and surface EMG interference pattern (SIP) has become popular as a …
potential (CMAP) and surface EMG interference pattern (SIP) has become popular as a …
A scoping review of current and emerging techniques for evaluation of peripheral nerve health, degeneration, and regeneration: Part 1, neurophysiology
Peripheral neuroregeneration research and therapeutic options are expanding
exponentially. With this expansion comes an increasing need to reliably evaluate and …
exponentially. With this expansion comes an increasing need to reliably evaluate and …